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The spectrum-effect relationship—a rational
approach for screening effective compounds
from Chinese herbal medicine
Chunsheng ZHU, Bing ZHANG, Zhijian LIN,
Xuejie WANG, Hongjuan NIU
School of Chinese Pharmacy, Beijing University of
Chinese Medicine
Purpose: Introduce a rational method for reﬂecting the
Chinese herbal medicine effective compositions and inter-
nal quality—the spectrum-effect relationship theory, so as
to provide ideas and references about screening the Chinese
herbal medicine effective components, distinguish different
herbal species and truly reﬂect the inner quality of Chinese
herbal medicine.
Methods: We systematically review the application of the
spectrum-effect relationship theory in the research of Chi-
nese herbal medicine, including research mentality, different
chromatographic analysis techniques, data processing tech-
nologies and structure determination.
Results: It is proved that, with the help of the spectrum-
effect relationship, the authenticationand identiﬁcationof the
Chinese herbal medicine can be accurately conducted even if
the concentration of effective components are not very similar
in different samples.
Conclusion: The spectrum-effect relationship is consid-
ered as a potential method to determine active ingredients in
complex mixtures and reﬂect the internal quality of Chinese
herbal medicine.
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Purpose: We performed a systematic review with meta-
analysis for Complementary and Alternative Medicine (CAM)
as deﬁned by the Cochrane Collaboration in hepatitis B and C.
Methods: A computerized search of databases (Cochrane
Library, Medline, PsychINFO, and Scopus) through June 2013
was performed. We screened the reference sections of original
studies and systematic reviews in English language for CAM in
hepatitis B and C. Randomized controlled trials (RCT) compar-
ing treatment to controls were assessed by the Cochrane risk
of bias tool. Where possible, meta-analyses were performed
using odds ratios (OR) with 95% conﬁdence intervals (CI).
Results: A total of 59 RCT were found, 12 in hepatitis B, 46
in hepatitis C and one in both. 23 studies could be included
in a meta-analysis. The risk of bias was heterogeneous in the
included studies. In hepatitis B meta-analysis was performed
for cyanidanol vs placebo. No effect on the biochemical mark-
ers (p=0.55) but a signiﬁcant effect on viral response (2 studies;
n=310; OR = 5.04; 95%CI 1.76-14.44; p=0.003) could be shown. In
hepatitis C meta-analysis showed a signiﬁcant effect on bio-
chemicalmarkers in vitaminDvsplacebo (2 studies; n=122;OR
= 7.94; 95%CI 2.86-2 2.03; p<0.0001) and on biochemical mark-
ers (5 studies; n=347; OR=1.87; 95%CI 1.20-2.90; p=0.0005) as
well as viral response (6 studies; n=380; OR=2.09; 95%CI 1.34-
3.27; p=0.001) in phlebotomie. No signiﬁcant effect could be
shown for vitaminCandE (2 studies; n=61), omega-3-fatty acid
(2 studies; n=62), silymarin (2 studies, n=293), zinc (5 studies,
n=256) or CH-100 (2 studies; n=131).
Conclusion: The average methodological quality of the
identiﬁed studies was heterogeneous. Best evidence was
found for cyanidanol in the treatment hepatitis B and vitamin
D and phlebotomie in the treatment of hepatitis C.
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systematic review of randomised clinical
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Purpose: Chinese herbal medicine (CHM) has been increas-
ingly used as an adjuvant treatment for multi-drug resistant
tuberculosis (MDR-TB) in China. To inform clinical practice,
we performed a systematic review on the beneﬁcial effect and
safety of CHM for MDR-TB.
Methods: We systematically searched the six electronic
databases for randomised clinical trials (RCTs) of CHM plus
chemotherapy for MDR-TB. RevMan 5.2 software was used for
data analyseswith effect estimates presented as risk ratio (RR)
with 95% conﬁdence interval (CI).
Results: 28 RCTs involving 3085 participants with MDR-
TB were included. The methodological quality was generally
poor in terms of risk of bias. Meta-analyses favoured CHM
plus chemotherapy on sputum bacteriological conversion rate
compared with chemotherapy alone after initiation of treat-
ment (6th mos: RR 1.29, 95% CI 1.14 to 1.46, n=11; 12th mos:
RR 1.38, 95% CI 1.19 to 1.59, n=5; 18th mos: RR 1.19, 95% CI
1.11 to 1.28, n=7). Compared with chemotherapy alone, meta-
analysis showedbeneﬁt fromCHMplus chemotherapy on lung
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lesions absorption rate (12th mos: RR 1.26, 95% CI 1.09 to 1.46,
n=3; 18th mos: RR 1.18, 95%CI 1.07 to 1.30, n=6) and pulmonary
cavity closure rate by radiological examination (18th mos: RR
1.24, 95%CI 1.01 to 1.51; n=4), relapse rate (RR 0.28, 95%CI 0.16
to 0.50, n=4), and abnormal liver function (RR 0.56, 95% CI 0.46
to 0.69, n=14).
Conclusion: CHM as an adjuvant to anti-TB chemotherapy
may have beneﬁcial effect for MDR-TB in terms of bacteriolog-
ical and radiological outcomes, and is safe. However, due to
poor methodology of the included trials, a conﬁrmative con-
clusion needs to be supported through further robust clinical
trial.
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Purpose: The Chinese Quality of Life Instrument (ChQOL)
is the ﬁrst patients reported outcome (PRO) established bas-
ing on the health concept of Traditional Chinese Medicine
(TCM) among most instruments based on Western culture. It
has been culturally adapted in China, Australia, France and
Hong Kong with satisfactory psychometric properties. ChQOL
consists of 50 items in 13 facets which are grouped in three
domains: (1) physical form, (2) vitality and spirit and (3) emo-
tion. However, the ChQOL was regarded as lengthy, which
hinders its application as an outcome measure. Therefore, we
aim at developing a brief version ranging from 13-26 items of
the ChQOL to ease administration and facilitate wider appli-
cation.
Methods: Two short forms of ChOQL (26-item or 13-item
with 1-2 items per facet) were developed by a secondary anal-
ysis (regression analysis and classical test theory), based on
empirical data of 1,410 of healthy to a wide range of diseases
severity subjects. These two short forms of ChQOL were val-
idated by (1) 20 registered Chinese Medicine practitioners on
the content and (2) a sample of 1,056 subjects, covering a range
of health status (fromhealthy to severely ill) inHongKong. The
brief versions of ChQOL were examined on the structure ﬁt-
ness, construct validity, equivalency when compared with the
full version.
Results: Complied with ISOPOR, the psychometric proper-
ties of two short forms were investigated and compared with
the full version.
Conclusion: The ﬁrst PRO, based on the health concept of
TCM,ChQOLwill be shortened to facilitate awider application.
The item reduction process is essential to advance of quality
of life study, like SF-36, WHOQOL. The shortening will also
improve completion rate with elderly who have low vision or
physical disability or serious illness. With easy interpretation,
ChQOL could be more readily incorporated into routine care,
or used in larger population studies.
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Selecting herbs for psoriasis based on
clinical, experimental and in-silico evidence
Brian May, Shiqiang Deng
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Purpose: This project aimed to select promising herbs for
treating psoriasis vulgaris based on the results of clinical,
experimental and in-silico studies and to explore the possible
actions of multiple compounds on multiple targets relevant to
this disease.
Methods: Meta-analysis of clinical trials combined with
reviews of experimental studies were used to short-list herbs
that showed promise of efﬁcacy for psoriasis vulgaris as well
as have anti-proliferative and/or anti-inﬂammatory actions.
Databases were used to identify the compounds contained in
the herbs, the protein targets of these compounds and the
metabolic pathways in which the proteins are involved.
Results: The clinical and experimental studies identiﬁed
12 herbs that showed evidence of efﬁcacy in clinical trials and
evidence of activity in experimental studies. These herbs con-
tained 60+ compounds which have been reported to act on
350+ proteins. Of these, multiple proteins were involved in
apoptosis, inﬂammation and angiogenesis. Proteins of known
relevance to psoriasis included Tumor Necrosis Factor and
Cyclooxygenasewhichwere down-regulated bymultiple com-
pounds in the herbs. Proteins relevant to apoptosis that were
regulated by multiple compounds included Apoptosis regula-
tor Bcl-2, Apoptosis regulator BAX, Caspase-3 and Caspase-9.
Multiple compounds were identiﬁed as inhibiting angiogene-
sis via Vascular Endothelial Growth Factor. Within some single
herbs, multiple compounds appeared to be acting on multiple
proteins within a pathway suggesting that its clinical actions
may be based on multi-compound multi-target effects.
Conclusion: This approach links the results of systematic
reviews and meta-analyses of clinical studies to the results
of experimental research by focusing on how compounds
contained in herbs could be acting on multiple proteins to
affect the inﬂammatory and proliferative processes involved
in psoriasis. The results indicate that multiple herbs contain
compounds that regulate known psoriasis targets as well as
other proteins that may be involved in the development and
or maintenance of psoriasis lesions.
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